Year archive

BCAL DIAGNOSTICS LIMITED — 2026 filings

All 18 regulatory filings released by BCAL DIAGNOSTICS LIMITED (BDX) in 2026, sourced directly from the official regulator.

18 Filings

2026 Period

2026 filings (18)

Filing	Released	Lang
BCAL Appoints Anne-Louise Arnett as Chief Executive Officer 4 pages 346.7KB Board/Management Information	2026-05-10	English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 531.1KB Interim / Quarterly Report Q3 2026	2026-04-21	English
BCAL Submits MSAC Application for Avantect Pancreatic Test 3 pages 256.4KB Regulatory Filings	2026-03-30	English
BCAL Accelerates Rollout of Avantect Early Detection Tests 2 pages 245.9KB Regulatory Filings	2026-03-25	English
Change of Director's Interest Notice 2 pages 196.8KB Regulatory Filings	2026-03-19	English
Change of Director's Interest Notice 2 pages 196.7KB Regulatory Filings	2026-03-18	English
Change of Director's Interest Notice 2 pages 196.7KB Regulatory Filings	2026-03-16	English
Application for quotation of securities - BDX 6 pages 19.1KB Regulatory Filings	2026-03-05	English
Cleansing Notice 1 page 182.6KB Regulatory Filings	2026-03-05	English
Change of Director's Interest Notice 2 pages 196.7KB Regulatory Filings	2026-02-19	English
BCAL Half Year Results Presentation December 2025 18 pages 2.3MB Regulatory Filings	2026-02-17	English
Half Yearly Report and Accounts 23 pages 8.4MB Regulatory Filings	2026-02-16	English
BCAL Webinar Review Half Year Results 18 February 11am AEDT 1 Regulatory Filings	2026-02-12	English
Shareholder Update 3 pages 282.9KB Regulatory Filings	2026-02-04	English
Initial Director's Interest Notice 2 pages 143.4KB Regulatory Filings	2026-02-02	English
Mr Mark McConnell Appointed to the Board 1 page 125 Regulatory Filings	2026-01-26	English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 398.3KB Regulatory Filings	2026-01-20	English
Change in substantial holding 5 pages 413.4KB Regulatory Filings	2026-01-18	English